# The IVO-LUNG Study

> **NCT07204548** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 63 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer (Stage III)

## Interventions

- **DRUG:** Ivonescimab

## Key facts

- **NCT ID:** NCT07204548
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2027-10
- **Final completion:** 2029-10
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07204548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07204548, "The IVO-LUNG Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07204548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*